These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3074767)
1. Role of monoclonal antibodies in the therapy of solid tumours. Tjandra JJ; Pietersz GA; Smyth MJ; McKenzie IF Aust N Z J Surg; 1988 Nov; 58(11):843-9. PubMed ID: 3074767 [No Abstract] [Full Text] [Related]
2. Monoclonal antibodies for therapy of human malignant tumours. Bergh JC Eur J Surg Suppl; 1991 May; (561):59-64. PubMed ID: 1720051 [No Abstract] [Full Text] [Related]
3. Targeting the vasculature of solid tumours. Murray JC; Hewett PW; Martin SG QJM; 1996 Mar; 89(3):165-7. PubMed ID: 8731559 [No Abstract] [Full Text] [Related]
4. [The use of monoclonal antibodies in the treatment of solid tumors]. Moiseenko VM Vopr Onkol; 1999; 45(4):458-62. PubMed ID: 10532114 [No Abstract] [Full Text] [Related]
5. Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases. Hafeez U; Gan HK; Scott AM Curr Opin Pharmacol; 2018 Aug; 41():114-121. PubMed ID: 29883853 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies in cancer therapy. Mellstedt H Curr Opin Immunol; 1989-1990; 2(5):708-13. PubMed ID: 2701972 [No Abstract] [Full Text] [Related]
7. Monoclonal antibody therapy for solid tumors. Green MC; Murray JL; Hortobagyi GN Cancer Treat Rev; 2000 Aug; 26(4):269-86. PubMed ID: 10913382 [TBL] [Abstract][Full Text] [Related]
9. Tumor targeting with monoclonal antibodies. Advances in the applications of monoclonal antibodies in clinical oncology. May 4-6, 1992, Porto Carras, Greece. Proceedings. Cell Biophys; 1992; 21(1-3):1-165. PubMed ID: 1285322 [No Abstract] [Full Text] [Related]
10. [Monoclonal antibodies and their potential application to medicine]. Weber S Z Erkr Atmungsorgane; 1985; 165(1):3-12. PubMed ID: 2414929 [TBL] [Abstract][Full Text] [Related]
11. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Dvorak HF; Nagy JA; Dvorak AM Cancer Cells; 1991 Mar; 3(3):77-85. PubMed ID: 1711364 [TBL] [Abstract][Full Text] [Related]
12. Challenges to the therapy of cancer with monoclonal antibodies. Goldenberg DM J Natl Cancer Inst; 1991 Jan; 83(2):78-9. PubMed ID: 1988690 [No Abstract] [Full Text] [Related]
13. Engineered affinity proteins for tumour-targeting applications. Friedman M; Ståhl S Biotechnol Appl Biochem; 2009 May; 53(Pt 1):1-29. PubMed ID: 19341363 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies in cancer therapy. Favrot MC; Combaret V; Philip T Pathol Biol (Paris); 1989 Feb; 37(2):99-100. PubMed ID: 2652083 [No Abstract] [Full Text] [Related]
15. Monoclonal antibodies: the possibilities for cancer therapy. Poynton CH; Reading CL Exp Biol; 1984; 43(1):13-33. PubMed ID: 6398221 [TBL] [Abstract][Full Text] [Related]
16. The present and future role of monoclonal antibodies in the management of cancer. Front Radiat Ther Oncol; 1990; 24():1-269. PubMed ID: 2341046 [No Abstract] [Full Text] [Related]
17. Monoclonal antibody therapy for cancer. Lovett DR; Scheinberg DA; Houghton AN Cancer Chemother Biol Response Modif; 1991; 12():147-63. PubMed ID: 1931442 [No Abstract] [Full Text] [Related]
18. Monoclonal antibody therapy of cancer. Jurcic JG; Scheinberg DA; Houghton AN Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215 [No Abstract] [Full Text] [Related]
19. Monoclonal antibodies in cancer immunotherapy. Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129 [TBL] [Abstract][Full Text] [Related]